Does LEUPROLIDE Cause Respiratory disorder? 82 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 82 reports of Respiratory disorder have been filed in association with LEUPROLIDE (Fensolvi). This represents 0.1% of all adverse event reports for LEUPROLIDE.
82
Reports of Respiratory disorder with LEUPROLIDE
0.1%
of all LEUPROLIDE reports
28
Deaths
58
Hospitalizations
How Dangerous Is Respiratory disorder From LEUPROLIDE?
Of the 82 reports, 28 (34.1%) resulted in death, 58 (70.7%) required hospitalization, and 5 (6.1%) were considered life-threatening.
Is Respiratory disorder Listed in the Official Label?
Yes, Respiratory disorder is listed as a known adverse reaction in the official FDA drug label for LEUPROLIDE.
What Other Side Effects Does LEUPROLIDE Cause?
Hot flush (9,146)
Death (8,772)
Intercepted product preparation error (8,621)
Syringe issue (7,847)
Device leakage (5,861)
Wrong technique in product usage process (5,062)
Fatigue (4,805)
Injection site pain (4,678)
Prostatic specific antigen increased (2,432)
Asthenia (2,176)
What Other Drugs Cause Respiratory disorder?
ADALIMUMAB (1,685)
METHOTREXATE (1,335)
ETANERCEPT (1,271)
PREDNISONE (1,053)
ABATACEPT (1,001)
TOCILIZUMAB (1,000)
LEFLUNOMIDE (952)
CERTOLIZUMAB PEGOL (923)
GOLIMUMAB (880)
ACETAMINOPHEN (869)
Which LEUPROLIDE Alternatives Have Lower Respiratory disorder Risk?
LEUPROLIDE vs LEVALBUTEROL
LEUPROLIDE vs LEVAMISOLE
LEUPROLIDE vs LEVAQUIN
LEUPROLIDE vs LEVEMIR
LEUPROLIDE vs LEVETIRACETAM